Software Bear Market: 1 SaaS Stock To Buy Now, 1 To Avoid

A recent AI-driven sell-off has hit software names hard after mixed results from sector leaders and the launch of Anthropic's Claude Cowork, with Axon and Atlassian highlighted as contrasting cases. Axon (down ~50% from its six‑month peak and ~25% in two weeks) is recommended as a buy due to its hardware-software ecosystem, Draft One generative-AI product, 31% projected revenue growth to $2.74B in FY2025 and a price-to-sales of ~14. By contrast Atlassian (revenue +23% to $1.6B in fiscal Q2, guiding +22% full‑year) is flagged to avoid: its stock is down ~72% over the last year, it has been GAAP unprofitable for a decade, and it spent >$800M (~30% of revenue) on stock-based comp in H1, leaving it exposed to AI-driven competition and shareholder dilution/buyback dynamics.

Analysis

Market structure: The sell-off reprices broad SaaS risk-premia and accelerates a rotation into AI infrastructure (NVDA, INTC) and niche hardware+recurring-revenue hybrids (AXON). losers are mid‑market collaboration/ITSM vendors (TEAM, NOW) where modular LLM-enabled tooling can substitute expensive license ARPU; winners gain pricing power from owning inference/ops layers and proprietary data flows. Option vols and credit spreads will likely widen near-term as earnings disappointments (MSFT, NOW) cascade, increasing hedging costs and bid for Treasuries in risk-off periods.

Risk assessment: Tail risks include regulatory action on public‑safety tech (facial-recognition bans, use-of-force litigation hitting AXON) and rapid commoditization of ticketing workflows by open-source LLM toolchains that would structurally compress TEAM ARPU. Time horizons: days—elevated volatility around quarterly prints; weeks–months—customer churn and enterprise AI pilot cadence will reveal durable wins; 12–36 months—structural market-share shifts as LLM stacks integrate into ERP/ITSM. Hidden dependencies: many incumbents rely on third‑party LLMs (Anthropic/OpenAI) and municipal procurement cycles that delay revenue recognition.

Trade implications: Tactical long AXON exposure is attractive for 12–24 months given 31% revenue growth guide and hardware lock‑in; target multiple expansion from PS 14 to 18–20 yields ~25–40% upside if execution holds. Tactical short/hedge TEAM: buy 6–9 month put spread (buy 30% OTM, sell 10% OTM) to capitalize on further downside as AI pilots scale and SB‑comp cash costs persist. Reallocate 5–10% portfolio weight from general SaaS into semis (NVDA) and security/hardware names (AXON) to capture infrastructure tailwinds while reducing pure SaaS beta.

Key Decisions for Investors

• Establish a 1.5–3% long position in AXON (AXON) sized to portfolio volatility for a 12–24 month horizon, adding incrementally if price/sales falls to ≤12x (another ~15% downside) and target exit when PS re-rates to 18–20x or on a 25–40% absolute gain.
• Open a protective bearish position on Atlassian (TEAM): buy a 6–9 month put spread (buy 30% OTM, sell 10% OTM) sized ~0.5–1% of portfolio to monetize continued ARPU pressure and share‑based comp dilution while capping premium outlay.
• Rotate 5–10% of broad SaaS exposure into AI infrastructure: buy NVDA (or equivalent ETF) using a 9–12 month call‑spread (buy ATM, sell 25–30% OTM) to capture secular GPU/AI demand with defined risk.
• Implement a pair trade: long AXON 2% vs short TEAM 1.5% (dollar‑neutral) to play hardware+recurring revenue resilience versus commoditization risk; rebalance after each earnings print (weekly monitoring for 30 days around prints).
• Monitor three high‑probability catalysts over the next 30–90 days before sizing up: (1) Anthropic/enterprise LLM adoption metrics (partner integrations count), (2) AXON municipal contract wins/backlog disclosures and 2025 revenue cadence, and (3) sequential ARPA/NRR trends from MSFT/NOW/TEAM; move to trim positions if NRR falls >3ppt QoQ or if regulatory actions on public‑safety tech escalate materially.